Published in J Neurol on January 01, 2005
Multiple sclerosis therapy: an update on recently finished trials. J Neurol (2007) 0.78
Induced Stem Cells as a Novel Multiple Sclerosis Therapy. Curr Stem Cell Res Ther (2016) 0.76
Importance of benefit-to-risk assessment for disease-modifying drugs used to treat MS. J Neurol (2004) 0.75
Assessing cost-effectiveness in the management of multiple sclerosis. Clinicoecon Outcomes Res (2009) 0.75
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol (1996) 10.39
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology (2001) 4.69
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial. Neurology (2002) 3.73
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS. Neurology (2002) 1.86
Evidence of interferon beta-1a dose response in relapsing-remitting MS: the OWIMS Study. The Once Weekly Interferon for MS Study Group. Neurology (1999) 1.13
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. J Neuroimmunol (1999) 1.09
Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance. Drug Saf (2003) 1.03
A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis. J Interferon Cytokine Res (2002) 0.92
Pharmacodynamic comparison of single doses of IFN-beta1a and IFN-beta1b in healthy volunteers. J Interferon Cytokine Res (1999) 0.83
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers. Pharm Res (1997) 0.80
Explaining differences in English hospital death rates using routinely collected data. BMJ (1999) 8.27
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52
Oceanic forcing of Sahel rainfall on interannual to interdecadal time scales. Science (2003) 5.06
The effect of carbon and nitrogen sources on the level of metabolic intermediates in Escherichia coli. J Biol Chem (1971) 4.84
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Is it possible and worth keeping track of deaths within general practice? Results of a 15 year observational study. Qual Saf Health Care (2003) 3.90
Narrative based medicine: why study narrative? BMJ (1999) 3.74
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial. Neurology (2002) 3.73
A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol (1973) 3.65
Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract (2001) 3.46
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med (1997) 3.32
A national database of medical error. J R Soc Med (1999) 2.96
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol (2011) 2.90
Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler (2011) 2.77
Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (2007) 2.77
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA (1999) 2.74
Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet (1990) 2.72
Doppler ultrasound examination of multiple sclerosis patients and control participants: inter-observer agreement and association with disease. Eur J Vasc Endovasc Surg (2013) 2.62
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Axillary breast tissue: clinical presentation and surgical treatment. Ann Plast Surg (1995) 2.46
Quantification of flow through an interatrial communication. Application to the partial Fontan procedure. J Thorac Cardiovasc Surg (1992) 2.39
Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37
Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med (1994) 2.35
Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol (1970) 2.35
Gallbladder contractility in patients with spinal cord injuries: a sonographic investigation. AJR Am J Roentgenol (1990) 2.24
The new out of hours agreement for general practitioners. BMJ (1995) 2.24
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22
Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. J Biol Chem (1994) 2.17
Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology (2004) 2.14
Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev (2006) 2.10
Seasonal patterns of bulimia nervosa. Am J Psychiatry (1992) 2.10
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Family support for stroke: a randomised controlled trial. Lancet (2000) 2.03
Opportunistic and reprehensible. Br Dent J (2006) 2.01
Bronchopulmonary foregut malformations. A unifying etiological concept. AJR Am J Roentgenol (1976) 1.98
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Development of a robust flow cytometric assay for determining numbers of viable bacteria. Appl Environ Microbiol (1995) 1.96
Joseph Rogers and the reform of workhouse medicine. BMJ (1989) 1.92
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J Exp Med (1993) 1.91
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol (1982) 1.91
Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care (2006) 1.87
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun (1992) 1.86
Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol (1983) 1.80
The role of zinc in caspase activation and apoptotic cell death. Biometals (2002) 1.80
Setting up a database of medical error in general practice: conceptual and methodological considerations. Br J Gen Pract (2001) 1.78
Changing motor synergies in chronic stroke. J Neurophysiol (2007) 1.77
Skin lesion with a fatal neurologic outcome (Degos' disease) Neurology (1996) 1.75
Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther (2008) 1.72
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Preconception care: who needs it, who wants it, and how should it be provided? Br J Gen Pract (1998) 1.70
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project. Gynecol Oncol (2009) 1.70
Seeking meaning and hope: self-reported spiritual and existential needs among an ethnically-diverse cancer patient population. Psychooncology (1999) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The neurohumoral axis in congestive heart failure. Ann Intern Med (1984) 1.66
Blood money: blood donors' attitudes to changes in the New Zealand blood transfusion service. BMJ (1996) 1.65
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol (1995) 1.65
Maximal exercise tolerance as a therapeutic end point in heart failure--are we relying on the right measure? Am J Cardiol (1994) 1.64
Clinical guidelines and the law. BMJ (1995) 1.64
Out of hours. BMJ (1994) 1.64
The art and science of searching MEDLINE to answer clinical questions. Finding the right number of articles. Int J Technol Assess Health Care (1999) 1.64
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther (2005) 1.64
Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. J Am Coll Cardiol (1992) 1.64
Antibiotics for acute bacterial conjunctivitis. Cochrane Database Syst Rev (2000) 1.63
The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis. Neurology (1998) 1.58
ACE inhibition in cardiovascular disease. N Engl J Med (2000) 1.58
Migraine with aura is a risk factor for cervical artery dissection: a case-control study. Cerebrovasc Dis (2010) 1.57
Cardiac troponins and chronic kidney disease. Kidney Int (2006) 1.57
Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol (2003) 1.57
Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J (1982) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56
The London handicap scale: a re-evaluation of its validity using standard scoring and simple summation. J Neurol Neurosurg Psychiatry (2000) 1.56
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Gastric metaplasia and chronic inflammation at the duodenal bulb mucosa. Dig Liver Dis (2003) 1.55
Coronary sinus ostial occlusion during retrograde delivery of cardioplegic solution significantly improves cardioplegic distribution and efficacy. J Thorac Cardiovasc Surg (1995) 1.55
HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups. Neurology (1993) 1.52
Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail (1995) 1.52
A visual migraine aura locus maps to 9q21-q22. Neurology (2010) 1.52
Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien) (2003) 1.52
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Garlic revisited: therapeutic for the major diseases of our times? J Natl Med Assoc (1988) 1.51
Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am J Respir Cell Mol Biol (1993) 1.50
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology (1995) 1.49
Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis (1981) 1.49
Characteristics of pronuclear migration in Beroe ovata. Cell Motil Cytoskeleton (1994) 1.48
Neurohumoral control mechanisms in congestive heart failure. Am Heart J (1981) 1.47
Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study. Neurology (2002) 1.46